These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31861689)

  • 1. Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study.
    Márquez E; Mora JR; Flores-Morales V; Insuasty D; Calle L
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of 5-aza-ellipticine derivatives.
    Moody DL; Dyba M; Kosakowska-Cholody T; Tarasova NI; Michejda CJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2380-4. PubMed ID: 17376678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.
    Shi LM; Fan Y; Myers TG; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    J Chem Inf Comput Sci; 1998; 38(2):189-99. PubMed ID: 9538518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
    Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
    ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
    Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
    Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, Biological Evaluation, and Molecular Modeling of 2-Difluoromethylbenzimidazole Derivatives as Potential PI3Kα Inhibitors.
    Wang X; Zhang M; Zhu R; Wu Z; Wu F; Wang Z; Yu Y
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
    Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
    Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern recognition methods investigation of ellipticines structure-activity relationships.
    de Melo LC; Braga SF; Barone PM
    J Mol Graph Model; 2007 Mar; 25(6):912-20. PubMed ID: 17049892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J
    Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
    Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors.
    Ma W; Wang Y; Chu D; Yan H
    J Mol Graph Model; 2019 Nov; 92():357-362. PubMed ID: 31450065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023.
    Hou W; Xu XL; Huang LJ; Zhang ZY; Zhou ZN; Wang JY; Ouyang X; Xin SY; Zhang ZY; Xiong Y; Huang H; Lan JX
    Chem Biodivers; 2024 May; 21(5):e202400210. PubMed ID: 38433548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of benzofuro[3,2-b]pyridin-2(1H)-one derivatives as anti-leukemia agents by inhibiting Btk and PI3Kδ.
    Liu L; Shi B; Li X; Wang X; Lu X; Cai X; Huang A; Luo G; You Q; Xiang H
    Bioorg Med Chem; 2018 Aug; 26(15):4537-4543. PubMed ID: 30077608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
    Yadav D; Nath Mishra B; Khan F
    J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise synthesis and antiproliferative activity evaluation of ellipticine quinone and its analogs.
    Nishiyama T; Hatae N; Mizutani M; Yoshimura T; Kitamura T; Miyano M; Fujii M; Satsuki N; Ishikura M; Hibino S; Choshi T
    Eur J Med Chem; 2017 Aug; 136():1-13. PubMed ID: 28477443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Human Topoisomerase II by N,N,N-Trimethylethanammonium Iodide Alkylcarbazole Derivatives.
    Saturnino C; Caruso A; Iacopetta D; Rosano C; Ceramella J; Muià N; Mariconda A; Bonomo MG; Ponassi M; Rosace G; Sinicropi MS; Longo P
    ChemMedChem; 2018 Dec; 13(24):2635-2643. PubMed ID: 30347518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine.
    Costa de Oliveira R; Soares Pontes G; Kostyuk A; Coutinho Camargo GB; Dhyani A; Shvydenko T; Shvydenko K; Grafov A
    Molecules; 2020 May; 25(9):. PubMed ID: 32370100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.